Jeffrey Velotta, MD
Dr. Jeffrey Velotta is a thoracic surgeon and Director of the Kaiser Permanente Northern California Mesothelioma Program and an adjunct assistant professor in the Department of Surgery at the University of California, San Francisco (UCSF) School of Medicine. His patient care centers on thoracic surgery, and he is particularly skilled in minimally invasive lung and esophageal surgery, image-guided surgical techniques for small lung nodules, and multimodality treatment of malignant pleural mesothelioma. He is committed to providing the best surgical services and excellent patient care.[1]
Education and Career
Dr. Velotta attended medical school at the George Washington University School of Medicine. After earning his medical degree, he completed an internship and residency in General Surgery at the University of California, Los Angeles (UCLA) Medical Center, concurrently completing a two-year postdoctoral research fellowship in the Department of Cardiothoracic Surgery at Stanford University School of Medicine. He also completed fellowship training in Cardiothoracic Surgery at the Brigham and Women’s Hospital, Harvard Medical School.[1]
In addition to his role as Director of the Kaiser Permanente Northern California Mesothelioma Program, Dr. Velotta is also a clinical Assistant Professor in the Department of Surgery at the University of California, San Francisco (UCSF) School of Medicine. He is a member of the American College of Surgeons and the Society of Thoracic Surgeons.
Research
Dr. Velotta’s research interests center on surgical quality about outcomes in minimally invasive surgeries for lung and esophageal cancer. He is currently involved in studies about novel ways to provide better pain relief after thoracic surgery, multimodality treatment of mesothelioma, and the incidence and outcomes for never-smokers with lung cancer.[1]
- Adjuvant Immunotherapy in Curative Intent Esophageal Cancer Resection Patients: Real-World Experience within an Integrated Health System. Cancers. Kwak, Hyunjee & Banks, Kian & Hung, Yun-Yi & Alcasid, Nathan & Susai, Cynthia & Patel, Ashish & Ashiku, Simon & Velotta, Jeffrey. (2023). 15. 5317. 10.3390/cancers15225317.
- Intervention to improve patient self-management and satisfaction in breast and lung cancers using the 4R Oncology model: Results by cancer, race and deprivation index. Weldon, Christine & Trosman, Julia & Linehan, Elizabeth & Gordon, Nancy & Hennings, Marti & James, Henie & Abbe, Thea & Katzel, Jed & Ng, Chun & Tomita, Megumi & Velotta, Jeffrey & Sakoda, Lori & Beringer, Kimberly & Ravelo, Arliene & Zhu, Zheng & Rapkin, Bruce & Liu, Raymond. (2023). JCO Oncology Practice. 19. 326-326. 10.1200/OP.2023.19.11_suppl.326.
- Does pre-operative mediastinal lymph node staging affect early-stage non-small cell lung cancer (SCLC) management? Tupper, Haley & Sarovar, Varada & Banks, Kian & Sun, Angela & Wile, Rachel & Barnes, Katherine & Ashiku, Simon & Patel, Ashish & Sakoda, Lori & Velotta, Jeffrey. (2023). Chest. 164. A4235-a4236. 10.1016/j.chest.2023.07.2758.
